Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05519982 · ClinicalTrials.gov registry record · NA
Sleep Treatment Education Program-1 (STEP-1)
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT05519982 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 70 participants.
The verdict
NCT05519982, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of the study is to learn if single session online education programs can help improve cancer survivors' sleep.
Interventions
- BEHAVIORAL Enhanced Usual Care
- BEHAVIORAL Sleep Treatment Education Program (STEP-1)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-03-10 |
| Est. Completion | 2024-10-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05519982
The ClinicalTrials.gov registry entry for NCT05519982 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care is the first listed.
NCT05519982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05519982 about?
NCT05519982 is a clinical study titled "Sleep Treatment Education Program-1 (STEP-1)". The purpose of the study is to learn if single session online education programs can help improve cancer survivors' sleep.
What is the current status of trial NCT05519982?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2023-03-10. Estimated completion is 2024-10-11.
What interventions are being tested in trial NCT05519982?
The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), Sleep Treatment Education Program (STEP-1) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05519982?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.